Crohn’s disease is a chronic inflammatory condition of the digestive tract that affects millions of people worldwide. Its symptoms — abdominal pain, diarrhoea, fatigue, weight loss, and bowel damage — can be debilitating and unpredictable. Despite significant advancements in medical therapy over the past decades, many patients still struggle to find lasting relief from standard treatment options. For a growing number of individuals, clinical trials are offering new hope — and real potential for better health outcomes.

In this article, we’ll explore why more Crohn’s patients are choosing clinical trials, how these studies work, and how organisations like Spoke Research are helping patients access cutting-edge treatment options while advancing the future of care.

We’ll also address common concerns about trial participation and highlight how to decide if a clinical trial might be right for you in 2026.

 

Why Conventional Treatment Isn’t Enough for Some Patients

Over the years, standard therapies for Crohn’s disease — including corticosteroids, immunomodulators, and biologic agents — have transformed disease management. These treatments help many patients achieve remission and reduce inflammation. However, a significant number of people continue to struggle with insufficient response to these medications or serious side effects. Some may even lose effectiveness over time.

When conventional therapy fails to manage disease activity or leads to intolerable adverse effects, patients often face a frustrating cycle of flare-ups and medication changes. In such situations, clinical trials become a critical alternative by offering novel therapies not yet available in routine clinical practice.

 

What Are Clinical Trials — and How Do They Work?

A clinical trial is a research study designed to evaluate the safety and effectiveness of new treatments, drugs, or medical approaches in humans. These trials follow strict scientific and ethical standards and proceed through phases:

• Phase I: Initial safety testing in a small group
• Phase II: Evaluating effectiveness and optimal dosage
• Phase III: Comparing new treatments with standard care in larger populations
• Phase IV: Long-term monitoring after approval

Each phase is carefully monitored by ethics committees and regulatory bodies to ensure participant safety. For many patients with Crohn’s disease, especially those with moderate to severe or refractory disease, clinical trials provide access to potentially more effective therapies before they are widely available.

Clinical trials may involve new biologics, small molecules, or innovative combinations of medications aimed at targeting inflammatory pathways more precisely than existing treatments.

 

What Motivates Patients to Join Clinical Trials?

Understanding why patients participate in clinical trials helps clarify the growing interest in research studies among people with Crohn’s disease.

Access to Cutting-Edge Treatments

One of the most compelling reasons patients choose clinical trials is the opportunity to receive innovative therapies ahead of general approval. Many clinical studies test next-generation treatments aimed at achieving longer remission, improved disease control, and fewer side effects than current options.

Enhanced Medical Monitoring

Participants in clinical trials often receive intensive follow-up care by specialists, including frequent lab tests, imaging, and symptom assessments. This level of attention can lead to better disease management and early detection of complications.

Contributing to Scientific Progress

Many patients are motivated by the opportunity to help others. Clinical trial participation contributes valuable data that advances research and can lead to future therapies that benefit patients worldwide.

Support When Standard Care Isn’t Enough

For patients whose disease remains active despite multiple therapies, trials may offer hope when other options have been exhausted. Researchers frequently design trials specifically for refractory Crohn’s disease, opening doors to novel treatment strategies.

Finally, studies show that patients who participate in trials often report improved outcomes and satisfaction with care when compared to their expectations.

 

 

How Spoke Research Is Helping Crohn’s Patients Find Relief

Clinical research companies like Spoke Research are playing a pivotal role in this landscape. Spoke Research is dedicated to conducting ethical, regulated clinical trials for inflammatory bowel diseases (IBD) — including both Crohn’s disease and ulcerative colitis.

A Patient-Focused Approach

Spoke Research emphasizes a compassionate, patient-first philosophy. The clinic’s teams are deeply invested in ensuring participants feel supported and informed throughout the trial process. Spoke teams conduct thorough pre-screening, provide transparent information, and guide patients through every step, from consent to follow-up.

Expertise and Care

Dedicated gastroenterologists and specialists lead trials at Spoke Research, offering participants access to expert medical insight and care — not just experimental treatments. This level of clinical experience provides an added layer of medical support for individuals navigating complex disease presentations.

Access to Global Innovations

By collaborating with pharmaceutical partners and research organisations, Spoke brings world-class treatment opportunities to local patients. For many, this is a chance to benefit from therapies that might otherwise be inaccessible or unaffordable.

How Trials Work at Spoke

Spoke Research’s clinical trials typically involve:

• Pre-screening and informed consent
• Baseline testing, including diagnostics and health questionnaires
• Treatment phases, where investigational treatments are administered under supervision
• Regular check-ins with healthcare professionals

Importantly, many IBD trials use add-on designs, meaning participants continue their usual treatments while testing the investigational therapy.

Addressing Common Patient Concerns 

Before joining a clinical trial, it’s normal to have questions or concerns. Here are some of the most common topics patients ask about.

Safety and Regulation

Clinical trials are highly regulated to ensure participant safety. In South Africa, all trials conducted by organisations like Spoke Research must meet standards approved by regulatory authorities and independent ethics committees. Continuous monitoring protects participants throughout the study.

Placebo Use

Not all clinical trials involve placebos, and even when a placebo arm exists, participants typically continue to receive standard care alongside the study protocol. Open-label or add-on designs are increasingly common, especially in IBD research.

Voluntary Participation

Participation in any clinical trial is completely voluntary, and patients can withdraw at any time without affecting their regular healthcare support.

 

The Role of Standard Diagnostic Care in Trials 

Participation in clinical trials doesn’t replace routine diagnostic care. For comprehensive disease evaluation, procedures such as colonoscopy play a critical role in assessing intestinal inflammation, disease distribution, and response to therapy. For authoritative information about colonoscopy and IBD care, you can visit Dr. Deetlefs.

Colonoscopy remains a cornerstone of monitoring disease activity and guiding therapeutic decisions, whether in standard practice or in trial settings.

 

How to Decide Whether a Clinical Trial Is Right for You

Choosing to participate in a clinical trial is a personal decision that should be made with careful consideration and consultation with your healthcare team. Here are practical steps:

Discuss With Your Gastroenterologist
Your doctor can help determine whether a trial aligns with your disease history, symptom pattern, and treatment goals.

Explore Reputable Clinical Trial Listings
Reliable resources like ClinicalTrials.gov provide searchable listings of ongoing studies worldwide.

Contact Research Organisations Directly
Clinics like Spoke Research can help screen for eligibility and explain the trial process in greater detail.

Looking Toward the Future of Crohn’s Treatment 

 

Clinical trials are central to advancing Crohn’s disease care. As therapies evolve and understanding of immune mechanisms deepens, research increasingly focuses on personalised treatment approaches and better long-term disease control. Participation in these trials not only offers potential personal benefit but also contributes to scientific progress that can improve care for future generations of patients with IBD.

With organisations like Spoke Research leading local and international collaborations, patients have more opportunities than ever to access promising new treatments while contributing to medical breakthroughs.

If you’ve struggled with persistent symptoms or feel that traditional therapies haven’t provided sufficient relief, exploring clinical trial options may be a significant step toward better outcomes. Speak with your gastroenterologist or contact a clinical research provider today to learn more.

Conclusion: Take the Next Step Toward Better Crohn’s Care 

Living with Crohn’s disease can feel unpredictable and overwhelming — especially when standard treatments no longer provide the relief you need. But you do not have to face another year of ongoing flares, discomfort, and uncertainty without exploring your options. Clinical trials are not a last resort; they are an important part of advancing modern medicine and expanding treatment possibilities for patients with moderate to severe Crohn’s disease.

At Spoke Research, our dedicated team focuses on ethical, patient-centered clinical trials for Crohn’s disease and ulcerative colitis. If your current treatment is not working, or if you are interested in learning more about investigational treatment options, we encourage you to reach out.

 

Contact Spoke Research 

📍 Location: 2nd Floor, 4, Golf Park Terraces, Raapenberg Rd, Pinelands
📞 Phone: 021 531 6402
🌐 Website: https://spokeresearch.co.za
📧 Email: info@spokeresearch.co.za

A new year brings new opportunities — and for many patients, that opportunity begins with research. If you are ready to explore advanced treatment options and take a proactive step toward better disease control, contact Spoke Research today.